Lower liver stiffness in patients with sustained virological response 4 years after treatment for chronic hepatitis C

European Journal of Gastroenterology and Hepatology

Volumn 23, Issue 1, 2011, Pages 41-44

  Andersen, Ellen Sloth ^a   Moessner, Belinda Klemmensen ^b   Christensen, Peer Brehm ^b,c   Kjær, Mette ^b,e   Krarup, Henrik ^f   Lillevang, Søren ^d   Weis, Nina ^a,e  

^a HVIDOVRE HOSPITAL   (Denmark)

^b Rigshospitalet   (Denmark)

^c Department of Infectious Diseases ^*  (Denmark)

^d ODENSE UNIVERSITY HOSPITAL   (Denmark)

^e UNIVERSITY OF COPENHAGEN   (Denmark)

^f AALBORG UNIVERSITY HOSPITAL   (Denmark)

Author keywords

fibrosis; hepatitis C; regression; transient elastography

Indexed keywords

ALANINE AMINOTRANSFERASE; HYALURONIC ACID; PEGINTERFERON; RIBAVIRIN;

ADULT; ARTICLE; DENMARK; ELASTOGRAPHY; FEMALE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HUMAN TISSUE; LIVER BIOPSY; LIVER CIRRHOSIS; LIVER FIBROSIS; LIVER STIFFNESS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; THROMBOCYTE COUNT; TRANSIENT ELASTOGRAPHY; TREATMENT RESPONSE; VIRUS DETECTION;

ALANINE TRANSAMINASE; ANTIVIRAL AGENTS; COHORT STUDIES; DENMARK; ELASTICITY IMAGING TECHNIQUES; FEMALE; HEPACIVIRUS; HEPATITIS C, CHRONIC; HUMANS; HYALURONIC ACID; INTERFERON ALFA-2A; INTERFERON ALFA-2B; LIVER; LIVER CIRRHOSIS; MALE; MIDDLE AGED; PLATELET COUNT; POLYETHYLENE GLYCOLS; RIBAVIRIN; TREATMENT OUTCOME;

EID: 78650784268     PISSN: 0954691X     EISSN: None     Source Type: Journal    
DOI: 10.1097/MEG.0b013e328341b891     Document Type: Article

References (19)

1. World Health Organization: WHO Fact Sheet N° 164, revised. October 2000.
2. Strader DB, Wright TL, Thomas DL, Seeff L. AASLD Practice Guideline: Diagnosis, management, and treatment of hepatitis C. Hepatology 2004; 39:1147-1171.
3. Fried MW, Shiffman ML, Reddy R, Smith C, Marinos G, Goncales FL Jr, et al. Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection. N Engl J Med 2002; 347:975-982.
4. Poynard T, McHutchison J, Manns M, Trepo C, Lindsay K, Goodman Z, et al. Impact of pegylated interferon alfa-2b and ribavirin on liver fibrosis in patients with chronic hepatitis C. Gastroenterology 2002; 122:1303-1313.
5. Toccaceli F, Laghi V, Capurso L, Koch M, Serno S, Scuderi M, et al. Longterm liver histology improvement in patients with chronic hepatitis C and sustained response to interferon. J Viral Hepat 2003; 10:126-133.
6. George SL, Bacon BR, Brunt EM, Mihindukulasuriya KL, Hoffmann J, Di Bisceglie AM. Clinical, virologic, histologic, and biochemical outcomes after successful HCV therapy: A 5-year follow-up of 150 patients. Hepatology 2009; 49:729-738.
7. Shiratori Y, Imazeki F, Moriyama M, Yano M, Arakawa Y, Yokosuka O, et al. Histologic improvement of fibrosis in patients with hepatitis C who have sustained response to interferon therapy. Ann Intern Med 2000; 132:517-524.
8. Marcellin P, Boyer N, Gervais A, Martinot M, Pouteau M, Castelnau C, et al. Long-term histologic improvement and loss of detectable intrahepatic HCV RNA in patients with chronic hepatitis C and sustained response to interferon-alfa therapy. Ann Intern Med 1997; 127:875-881.
9. Ogawa E, Furusyo N, Toyoda K, Takeoka H, Maeda S, Hayashi J. The longitudinal quantitative assessment by transient elastography of chronic hepatitis C patients treated with pegylated interferon alpha-2b and ribavirin. Antiviral Res 2009; 83:127-134.
10. Andersen ES, Christensen PB, Weis N. Transient elastography for liver fibrosis diagnosis. Eur J Intern Med 2009; 20:339-342.
11. Verveer C, De Knegt RJ. Non-invasive measurement of liver fibrosis: Application of the FibroScan in hepatology. Scand J Gastroenterol 2006; 41:85-88.
12. Ganne-Carrié N, Ziol M, De Lédinghen V, Douvin C, Marcellin P, Castera L, et al. Accuracy of liver stiffness measurement for the diagnosis of cirrhosis in patients with chronic liver diseases. Hepatology 2006; 44:1511-1517.
13. Kettaneh A, Marcellin P, Douvin C, Poupon R, Ziol M, Beaugrand M, et al. Features associated with success rate and performance of FibroScan measurements for the diagnosis of cirrhosis in HCV patients: A prospective study of 935 patients. J Hepatol 2007; 46:628-634.
14. Foucher J, Chanteloup E, Vergniol J, Castera L, Le Bail B, Adhoute X, et al. Diagnosis of cirrhosis by transient elastography (FibroScan): A prospective study. Gut 2006; 55:403-408.
15. Friedrich-Rust M, Ong M-F, Martens S, Sarrazin C, Bojunga J, Zeuzem S, et al. Performance of transient elastography for the staging of liver fibrosis: A meta-analysis. Gastroenterology 2008; 134:960-974.
16. Smith BC, Grove J, Guzail MA, Day CP, Daly AK, Burt AD, et al. Heterozygosity for hereditary hemochromatosis is associated with more fibrosis in chronic hepatitis C. Hepatology 1998; 27:1695-1699.
17. Sagir A, Erhardt A, Schmitt M, Häussinger D. Transient elastography is unreliable for detection of cirrhosis in patients with acute liver damage. Hepatology 2008; 47:592-595.
18. Arena U, Vizzutti F, Corti F, Ambu S, Stasi C, Bresci S, et al. Acute viral hepatitis increases liver stiffness values measured by transient elastography. Hepatology 2008; 47:380-384.
19. Mallet V, Gilgenkrantz H, Serpaggi J, Verkarre V, Vallet-Pichard A, Fontaine H, et al. Brief communication: The relationship of regression of cirrhosis to outcome in chronic hepatitis C. Ann Intern Med 2008; 149:399-404.